Viewing nowCombinationVidiFin Tablet 2.5/80mg (Amlodipine, Valsartan)
Amlodipine Besylate 3.472mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202600553 · Approved 2026.02.24
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with Amlodipine or Valsartan used alone. It effectively lowers blood pressure, helping to reduce the risk of complications arising from hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual ingredients as described below, switching directly to this medicine may be considered. ㆍ2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with valsartan 80 milligrams as monotherapy. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, administration of this drug is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any ingredients in this medication, those who are pregnant or breastfeeding, and patients with severe kidney or liver dysfunction should not take this medication. Patients who are sodium or fluid depleted should check their condition before taking this medication and supplement if necessary, and take immediate appropriate measures if symptoms of hypotension occur. Patients with high potassium levels should be cautious when taking this medication along with potassium supplements or potassium-sparing diuretics and should frequently check their blood potassium levels. Patients with vascular issues in the kidneys or those who have recently undergone kidney transplantation should use this medication with caution, as it may affect kidney function. If symptoms of angioedema occur, the medication must be discontinued immediately and should not be re-administered. Patients with heart failure or after a myocardial infarction should take this medication while periodically monitoring kidney function. Patients with acute myocardial infarction or aortic stenosis should also be cautious when taking this medication. The use of this medication in combination with other Renin-Angiotensin-Aldosterone System agents increases the risk of hypotension, worsening kidney function, and hyperkalemia, so combinations should be avoided or used under strict medical supervision. Dizziness or fatigue may occur while driving or operating machinery, so caution is advised. During treatment with this medication, it is important to regularly check for abnormal blood pressure, kidney function, and potassium levels. In case of overdose, severe hypotension or cardiac function deterioration may occur, requiring immediate hospital treatment. The safety and efficacy of this medication in children under 18 years of age have not been adequately established, so its use is not recommended. Elderly patients can take the usual adult dose, but it is important to monitor their physical condition closely.
Increased alanine aminotransferase, increased aspartate aminotransferase, increased alkaline phosphatase in blood, increased creatinine in blood, increased gamma-glutamyl transferase, increased triglycerides in blood, increased liver enzymes, upper respiratory tract infection, soft tissue infection, chest discomfort, generalized edema, chest pain, muscle cramps, plantar fasciitis, dizziness, headache, insomnia, sleep disturbances, palpitations, ventricular extrasystole, cystic hygroma, hypothyroidism, colon polyps, leukocyturia, pneumothorax, hypertension, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, heart palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, lethargy, polyuria, nocturia, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorders, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuralgia, sensory loss, Stevens-Johnson syndrome, dizziness, fatigue, rapid blood pressure drop, hypotension, syncope, increased blood urea, increased serum creatinine, increased BUN, acute renal failure, death, pulmonary edema, angina, acute myocardial infarction, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it should be kept away from areas that are too hot or too cold, ideally in a temperature range of 1 to 30 degrees Celsius.
Bright yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 3.472mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.